Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Non Operating Interest Expenses (2012 - 2013)

Updated

Bristol Myers Squibb (BMY) recorded Non Operating Interest Expenses of $50 million in Q1 2013, up 19.0% from $42 million a year earlier.

Analysis

Bristol Myers Squibb (BMY) Non Operating Interest Expenses (2012 - 2013) Analysis & Trends

For FY2012, Bristol Myers Squibb reported Non Operating Interest Expenses of $182 million, up 25.5% from FY2011.

  • Annual Non Operating Interest Expenses has a three-year compound annual growth rate of -0.4% (FY2009 to FY2012).
  • Across earlier years, Non Operating Interest Expenses came in at $145 million in FY2011 (unchanged), $145 million in FY2010 (-21.2%) and $184 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 217.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -477.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 50.00 Mn
Mar 31, 2012 42.00 Mn
API Access

Bristol Myers Squibb Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEY